Master gene reprogramming and the development of prostate cancer

According to an hypothesis just published by a group of researchers at the Dana-Farber Cancer Institute in Boston, they have identified “a new epigenetic program occurring as you transition from normal to tumor cells” in the development of prostate cancer. … READ MORE …

Could EZH2 be critical to castration resistance?

According to an article published in Science on Friday last week, activation of an epigenetic regulator known as EZH2 (“enhancer of zeste homolog 2”) may be critical to the onset and progression of castration-resistant prostate cancer (CRPC). … READ MORE …

Epigenetics and prostate cancer revisited

We have commented before on the potential of epigenetics in the development of innovative therapies for the management of prostate cancer. … READ MORE …

When it comes to epigenetics, keep your optimism under control

If you’ve been hoping that research in the field of epigenetics is going to bring us a cure for prostate cancer in the next few years, dream on! … READ MORE …

Prostate cancer news reports: Friday, June 26, 2009

Today’s prostate cancer news report summary includes items dealing with:

  • The epigenetics of prostate cancer and their potential importance
  • Selenium + vitamin E + lycopene (in mice)
  • Gleason 7: 4 + 3 versus 3 + 4 — it’s important
  • Proton beam radiotherapy — a topical review
  • EBRT + low dose, permanent seed brachytherapy … READ MORE …